William Blair Investment Management LLC Has $147.53 Million Stake in Chemed Corporation $CHE

William Blair Investment Management LLC trimmed its holdings in shares of Chemed Corporation (NYSE:CHEFree Report) by 10.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 344,807 shares of the company’s stock after selling 40,317 shares during the quarter. William Blair Investment Management LLC’s holdings in Chemed were worth $147,529,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors also recently made changes to their positions in CHE. Smartleaf Asset Management LLC grew its position in shares of Chemed by 71.4% in the third quarter. Smartleaf Asset Management LLC now owns 60 shares of the company’s stock valued at $27,000 after purchasing an additional 25 shares during the last quarter. BOK Financial Private Wealth Inc. acquired a new stake in shares of Chemed in the fourth quarter valued at about $27,000. Global Retirement Partners LLC grew its position in shares of Chemed by 200.0% in the fourth quarter. Global Retirement Partners LLC now owns 87 shares of the company’s stock valued at $37,000 after purchasing an additional 58 shares during the last quarter. Pilgrim Partners Asia Pte Ltd acquired a new stake in shares of Chemed in the third quarter valued at about $45,000. Finally, Danske Bank A S grew its position in shares of Chemed by 250.0% in the fourth quarter. Danske Bank A S now owns 140 shares of the company’s stock valued at $60,000 after purchasing an additional 100 shares during the last quarter. 95.85% of the stock is owned by institutional investors and hedge funds.

Wall Street Analyst Weigh In

Several equities research analysts have recently issued reports on CHE shares. Wall Street Zen downgraded Chemed from a “buy” rating to a “hold” rating in a research report on Saturday. Oppenheimer lowered their price target on Chemed from $580.00 to $500.00 and set an “outperform” rating on the stock in a research report on Friday, February 27th. Zacks Research raised Chemed from a “strong sell” rating to a “hold” rating in a research report on Monday, April 27th. Weiss Ratings upgraded shares of Chemed from a “sell (d+)” rating to a “hold (c-)” rating in a research note on Wednesday, April 29th. Finally, Royal Bank Of Canada increased their target price on shares of Chemed from $422.00 to $436.00 and gave the company a “sector perform” rating in a research note on Monday, April 27th. Two analysts have rated the stock with a Buy rating and four have given a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $501.50.

View Our Latest Stock Analysis on CHE

Chemed Stock Down 0.4%

NYSE CHE opened at $439.70 on Friday. The company has a debt-to-equity ratio of 0.11, a quick ratio of 0.83 and a current ratio of 0.85. The firm has a 50-day simple moving average of $400.27 and a 200 day simple moving average of $425.05. Chemed Corporation has a twelve month low of $365.20 and a twelve month high of $581.20. The stock has a market cap of $5.83 billion, a PE ratio of 23.96, a PEG ratio of 1.65 and a beta of 0.54.

Chemed (NYSE:CHEGet Free Report) last released its earnings results on Thursday, April 23rd. The company reported $5.65 earnings per share for the quarter, beating the consensus estimate of $5.30 by $0.35. Chemed had a net margin of 10.23% and a return on equity of 27.18%. The business had revenue of $657.51 million during the quarter, compared to analysts’ expectations of $659.22 million. During the same quarter last year, the company earned $5.63 earnings per share. The firm’s revenue was up 1.6% on a year-over-year basis. Chemed has set its FY 2026 guidance at 24.000-24.75 EPS. On average, research analysts forecast that Chemed Corporation will post 22.3 EPS for the current year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 16th. Investors of record on Thursday, May 28th will be paid a $0.60 dividend. This represents a $2.40 annualized dividend and a dividend yield of 0.5%. The ex-dividend date is Thursday, May 28th. Chemed’s dividend payout ratio (DPR) is presently 13.08%.

Insider Buying and Selling at Chemed

In related news, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction dated Friday, May 1st. The shares were sold at an average price of $421.13, for a total value of $842,260.00. Following the completion of the sale, the chief executive officer owned 90,219 shares in the company, valued at approximately $37,993,927.47. This trade represents a 2.17% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 3.33% of the company’s stock.

Chemed Company Profile

(Free Report)

Chemed Corporation is a diversified provider of essential home services and healthcare solutions in the United States. Headquartered in Cincinnati, Ohio, the company operates through two principal business segments—Roto-Rooter and Vitas Healthcare. Since its founding in 1974, Chemed has built a reputation for reliability and expertise, serving both residential and commercial customers across a broad range of markets.

The Roto-Rooter segment offers a comprehensive suite of plumbing, drain cleaning and water restoration services.

See Also

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Corporation (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.